Brief: Bioporto - FY EBIT DKK 74 mln

BioPorto A/S

26/02/2020 07:57

Feb 26 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO ANNOUNCES PRELIMINARY FINANCIAL RESULT FOR 2019, GUIDANCE FOR 2020 AND
POSTPONES
PUBLICATION OF AUDITED ANNUAL REPORT FOR 2019 TO MARCH 11, 2020. A PRIVATE PLACEMENT OF NEW
SHARES ARE BEING PURSUED TO STRENGTHEN FINANCIAL POSITION.
    * BIOPORTO A/S - REVENUE FOR 2019 WAS DKK 26.6 MILLION (2018: DKK 26.0 MILLION)
    * BIOPORTO A/S - BIOPORTO EXPECTS REVENUE OF APPROXIMATELY DKK 30 MILLION IN 2020
    * BIOPORTO A/S - EXPECTS TO INCUR AN OPERATING LOSS (EBIT) OF APPROXIMATELY DKK 73 MILLION
AFFECTED BY FULL YEAR IMPACT OF 2019 HIRES AND BY HIGHER COSTS RELATED TO CLINICAL STUDIES.
    * BIOPORTO A/S - IT IS EXPECTED THAT REVENUE WILL BE BACK-END LOADED, WITH APPROXIMATELY ONE
THIRD
OF REVENUES IN 1H 2020, ONE THIRD OF REVENUES IN Q3 OF 2020 AND ONE THIRD OF REVENUES IN Q4 OF
2020
    * BIOPORTO A/S - FY EBIT DKK 74 MILLION VERSUS LOSS DKK 41.8 MILLION YEAR AGO
    * BIOPORTO A/S - GUIDANCE DOES NOT INCLUDE ANY SALES OF AN FDA-CLEARED NGAL TEST IN US IN
2020

Source text for Eikon:  ID:nGNE8HHH9 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))